$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Itraconazole: an effective oral antifungal for onychomycosis

International journal of dermatology, v.40 no.1, 2001년, pp.1 - 5  

Jain, Sanjeev (Skin Care Clinic, Darya Ganj, New Delhi, and Dermato‐) ,  Sehgal, Virendra N. (Venereology (Skin)

초록이 없습니다.

참고문헌 (51)

  1. J Med Chem Heeres J 894 27 1984 10.1021/jm00373a015 Antimycotic azoles. Synthesis and anti‐fungal properties of a series of novel triazol‐3‐ones 

  2. Br J Clin Pract Van Den Bossche H 41 44 71 1990 Biochemical basis for the activity and selectivity of oral anti‐fungals 

  3. Bailey, Elaine M., Krakovsky, David J., Rybak, Michael J.. The Triazole Antifungal Agents: A Review of Itraconazole and Fluconazole. Pharmacotherapy, vol.10, no.2, 146-153.

  4. Bossche, H. Vanden, Marichal, P., Gorrens, J., Coene, M. C., Willemsens, G., Bellens, D., Roels, I., Moereels, H., Janssen, P. A. J.. Biochemical Approaches to Selective Antifungal Activity. Focus on Azole Antifungals. Mycoses, vol.32, no.1, 35-52.

  5. Mycoses Van Custem J. 7 32 1 1989 The in vitro anti‐fungal spectrum of itraconazole 

  6. Hazen, Kevin C.. Fungicidal versus fungistatic activity of terbinafine and itraconazole: An in vitro comparison. Journal of the American Academy of Dermatology, vol.38, no.5, S37-S41.

  7. Gupta, Aditya K., Scher, Richard K., De Doncker, Piet. CURRENT MANAGEMENT OF ONYCHOMYCOSIS. Dermatologic clinics, vol.15, no.1, 121-135.

  8. Mycoses Van Custem J. 14 32 1 1989 Oral, topical and parenteral anti‐fungal treatment with itraconazole in normal and immuno‐compromised animals 

  9. Rev Infect Dis Van Custem J 15 9 1987 10.1093/clinids/9.Supplement_1.S15 Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycosis: animal models 

  10. Piérard, G.E, Arrese, J.E, De Doncker, P. Antifungal activity of itraconazole and terbinafine in human stratum corneum: A comparative study. Journal of the American Academy of Dermatology, vol.32, no.3, 429-435.

  11. Van Peer, A., Woestenborghs, R., Heykants, J., Gasparini, R., Gauwenbergh, G.. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects. European journal of clinical pharmacology, vol.36, no.4, 423-426.

  12. Meuldermans W&Heykents J.The plasma protein binding of itraconazole and its distribution in blood. Data on file.Janssen Research Foundation R 51 211/33. Location?: Janssen Research Foundation1986. 

  13. Cauwenbergh, G., Degreef, H., Heykants, J., Woestenborghs, R., Van Rooy, P., Haeverans, K.. Pharmacokinetic profile of orally administered itraconazole in human skin. Journal of the American Academy of Dermatology, vol.18, no.2, 263-268.

  14. MATTHIEU, L., DONCKER, P., CAUWENBERGH, G., WOESTENBORGHS, R., VELDE, V., JANSSEN, P.A.J., DOCKX, P.. Itraconazole penetrates the nail via the nail matrix and the nail bed-an investigation in onychomycosis. Clinical and experimental dermatology, vol.16, no.5, 374-376.

  15. Willemsen, M., De Doncker, P., Willems, J., Woestenborghs, R., Van de Velde, V., Heykants, J., Van Cutsem, J., Cauwenbergh, G., Roseeuw, D.. Posttreatment itraconazole levels in the nail. Journal of the American Academy of Dermatology, vol.26, no.5, 731-735.

  16. Arch Dermatol De Doncker P 34 132 1996 Anti‐fungal pulse therapy for onychomycosis 

  17. Recent Trends in the Discovery, Development and Evaluation of Anti‐Fungal Agents. Heykants J 1987 

  18. Heykants, J., Van Peer, A., Van de Velde, V., Van Rooy, P., Meuldermans, W., Lavrijsen, K., Woestenborghs, R., Van Cutsem, J., Cauwenbergh, G.. The Clinical Pharmacokinetics of Itraconazole: An Overview. Mycoses, vol.32, no.1, 67-87.

  19. Boelaert J Sas S Van Peer A&De Doncker P.Pharmacokinetics of itraconazole in renal dysfunction.26th International Scientific Conference on Antimicrobial Agents and ChemotherapySeptember 28-October 1 1986 New Orleans. 1986: (Abstract) 801. 

  20. Levron JC Chwetzoff E&Perrichon Pet al.Pharmacokinetics of itraconazole in cirrhotic patients. Data on file.Janssen Research Foundation N 74705.Janssen Research Foundation. 

  21. HAY, R. J., CLAYTON, Y. M., MOORE, M. K., MIDGELY, G.. An evaluation of itraconazole in the management of onychomycosis. British journal of dermatology : BJD, vol.119, no.3, 359-366.

  22. Hay, R.J., Clayton, Y.M., Moore, M.K., Midgely, G.. Itraconazole in the management of chronic dermatophytosis. Journal of the American Academy of Dermatology, vol.23, no.3, 561-564.

  23. 10.1093/jac/29.2.195 

  24. Acta Derm Venereol Walsoe I 137 70 1990 10.2340/0001555570137140 Itraconazole in onychomycosis: open and double blind studies 

  25. Br J Clin Pract Difonzo EM 44 9 1990 Itraconazole in dermatophyte infections: clinical experience in Italy 

  26. Rongioletti, F., Robert, E., Tripodi, S., Persi, A.. Treatment of onychomycosis with itraconazole. The Journal of dermatological treatment, vol.2, no.4, 145-146.

  27. ARENAS, ROBERTO, DOMÍNGUEZCHERIT, JUDITH, FERNANDEZ, LUISA MA.. OPEN RANDOMIZED COMPARISON OE ITRACONAZOLE VERSUS TERBINAEINE IN ONYCHOMYCOSIS. International journal of dermatology, vol.34, no.2, 138-143.

  28. J Am Acad Dermatol Roseuw D 138 34 1993 New approaches to the treatment of onychomycosis 

  29. Eur J Dermatol Haneke E 7 6 1996 The use of itraconazole in onychomycosis 

  30. Cutis Elewski BE 217 59 4 1997 Double blind, randomized comparison of itraconazole capsules vs placebo in the treatment of toenail onychomycosis 

  31. Acta Derm Venereol Heikkila H 70 77 1 1997 10.2340/00015555777071 Long term results of patients with onychomycosis treated with itraconazole 

  32. HAVU, V., BRANDT, H., HEIKKILÄ, H., HOLLMEN, A., OKSMAN, R., RANTANEN, T., SAARI, S., STUBB, S., TURJANMAA, K., PIEPPONEN, T.. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. British journal of dermatology : BJD, vol.136, no.2, 230-234.

  33. Cutis De Doncker P 180 56 1995 Pulse therapy with one‐week itraconazole monthly for three or four months in the treatment of onychomycosis 

  34. Andre J&Havu V.European experiences with itraconazole pulse therapy in the treatment of toenail onychomycosis.Proceedings of the 2nd International Symposium on Onychomycosis Florence Italy September 28-29 1995 Cheshire UK. Gardiner‐Caldwell Communications 1995 :22-25. 

  35. Ginter G.Antifungal pulse therapy in toenail onychomycosis. Austrian experience.Proceedings of the 2nd International Symposium on Onychomycosis Florence Italy September 28-29 1995 Cheshire UK. Gardiner‐Caldwell Communications 1995 :26-27. 

  36. Elewski B.Itraconazole pulse therapy for the treatment of fingernail onychomycosis.Proceedings of the 2nd International Symposium on Onychomycosis Florence Italy September 28-29 1995 Cheshire UK. Gardiner‐Caldwell Communications 1995 :28-30. 

  37. Haneke E Ring J&Schrooten Met al.Itraconazole in the treatment of onychomycosis: an open multi‐centre trial to investigate the efficacy and safety of itraconazole pulse therapy.Janssen Research Foundation Clinical Research Report ITR‐GER‐18. Janssen Research FoundationApril 1995. 

  38. Havu V De Doncker P&Joosen Het al.Effect of itraconazole in the treatment of onychomycosis of toenails. A randomized double‐blind trial comparing continuous treatment with pulse therapy.Janssen Research Foundation Report ITR‐FIN‐1. Janssen Research FoundationMarch 1995. 

  39. Zaias N Elewski B&Scher RKet al.Effect of itraconazole intermittent therapy in the treatment of onychomycosis of fingernails. A randomized double‐blind comparison with placebo.Janssen Research Foundation Clinical Research Report ITR‐USA‐71. Janssen Research FoundationApril 1995. 

  40. Decroix J De Doncker P&Cornwell Let al.Itraconazole in the treatment of onychomycosis: an open randomized trial to evaluate the efficacy and tolerability of three or four months intermittent therapy with itraconazole.Janssen Research Foundation Clinical Research Report ITR‐BEL‐43. Janssen Research FoundationMarch 1995. 

  41. Hermans A.Clinical expert summary on itraconazole for the treatment of onychomycosis with a shortened regime of 200 mg b.i.d. × 7 day/month for 2-3 months.Janssen Research Foundation Clinical Research Report N 111 629M. Janssen Research Foundation19951-44. 

  42. Haneke E Ring J&Tajerbashi Det al.Efficacy and safety of itraconazole 1 week pulse therapy in the treatment of onychomycosis: an open German multicentre trial.Poster presented at the 54th Annual Meeting of the American Academy of Dermatology Washington DCFebruary 1015 1996. 

  43. Andre J De Doncker P&Ginter Get al.International therapy with itraconazole in onychomycosis: an update.Poster presented at the 54th Annual Meeting of the American Academy of Dermatology Washington DCFebruary 1015 1996. 

  44. Li WD Ping WA&Wang Ret al.Therapeutic efficacy of intermittent pulse therapy with itrasonazole in onychomycosis: a Chinese multicentre trial.Poster presented at the 54th Annual Meeting of the American Academy of Dermatology Washington DCFebruary 1015 1996. 

  45. Bonifaz, Alexandro, Carrasco‐Gerard, Eugenio, Saul, Amado. Itraconazole in onychomycosis: intermittent dose schedule. International journal of dermatology, vol.36, no.1, 70-72.

  46. Wu, J., Wen, H., Liao, W.. Small‐dose itraconazole pulse therapy in the treatment of onychomycosis. Mycoses, vol.40, no.9, 397-400.

  47. Odom, Richard B., Aly, Raza, Scher, Richard K., Daniel III, C.Ralph, Elewski III, Boni E., Zaias III, Nardo, DeVillez III, Richard, Jacko III, Mary, Olekag III, Napoleon, Moskovitz III, Bruce L.. A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail. Journal of the American Academy of Dermatology, vol.36, no.2, 231-235.

  48. De Doncker, Piet R.G., Scher, Richard K., Baran, Robert L., Decroix, J., Degreef, Hugo J., Roseeuw, Diane I., Havu, V., Rosen, Theodore, Gupta, Aditya K., Piérard, Gerald E.. Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients. Journal of the American Academy of Dermatology, vol.36, no.2, 173-177.

  49. Acta Derm Venereol Heikkila H 70 77 1997 10.2340/00015555777071 Long term results of patients with onychomycosis treated with itraconazole 

  50. Kullavanijaya P Lingpakron R&Reangchainam S.Itraconazole in the treatment of onychomycosis: an open randomized trial to evaluate the efficacy and tolerability of intermittent therapy with itraconazole.Poster presented at Clinical Dermatology SingaporeJune 1820 2000. 

  51. Kim, Jeong-Aee, Ahn, Kyu-Joong, Kim, Jong-Min, Youn, Jai-Il. Efficacy and tolerability of itraconazole in patients with fingernail onychomycosis: a 6-week pilot study. Current therapeutic research, vol.56, no.10, 1066-1075.

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로